Company Profile

Abwiz Bio Inc
Profile last edited on: 11/6/19      CAGE:       UEI: NL12MYXYBMA1

Business Identifier: Rabbit monoclonal antibody prroduction
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9823 Pacific Heights Boulevard Suite J
San Diego, CA 92121
Location: Single
Congr. District: 52
County: San Diego

Public Profile

Abwiz Bio Inc. is organized around development of novel monoclonal antibody development biotechnology with a current focus on novel therapeutic reagents for food allergies. The prevalence of food allergies have been dramatically increasing for the last few decades with an estimated 15 million Americans have food allergies. Signs and symptoms of food allergies range from itching, hives and diarrhea to life-threatening anaphylaxis. Work by the firm's principals suggest that histamine-releasing factor mediated activation of mast cells and basophils is required for food allergies. The company specializes in monoclonal antibody developmen, providing researcher with high-quality, high affinity, phospho specific monoclonal antibodies for flow symmetry through a stage of art rabbit antibody technology that includes a unique learning method and optimal expression system.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NIH $600,000
Project Title: Engineering a Unique Antibody for Patients with RA
2016 1 NIH $229,600
Project Title: Blockade of Histamine-Releasing Factor as a New Prophylactic and Therapeutic Strategy for Food Allergy

Key People / Management

  Cj Okumura -- Founder and CEO

  Toshiaki Maruyama Kawakami

  Toshi Maruyama -- Founder and COO/CSO

Company News

There are no news available.